000919 金陵药业
已收盘 08-25 15:00:00
资讯
新帖
简况
金陵药业(000919)8月10日股东户数4.06万户,较上期增加0.05%
证券之星 · 08-18
金陵药业(000919)8月10日股东户数4.06万户,较上期增加0.05%
金陵药业:截至2026年8月10日,公司股东人数为40,565
证券之星 · 08-18
金陵药业:截至2026年8月10日,公司股东人数为40,565
金陵药业(000919)7月31日股东户数4.05万户,较上期减少2.92%
证券之星 · 08-11
金陵药业(000919)7月31日股东户数4.05万户,较上期减少2.92%
金陵药业:截至2026年7月31日,公司股东人数为40,543
证券之星 · 08-11
金陵药业:截至2026年7月31日,公司股东人数为40,543
金陵药业(000919)7月31日股东户数4.05万户,较上期减少2.92%
证券之星 · 08-05
金陵药业(000919)7月31日股东户数4.05万户,较上期减少2.92%
金陵药业:截至2026年7月31日,公司股东人数为40,543
证券之星 · 08-05
金陵药业:截至2026年7月31日,公司股东人数为40,543
金陵药业(000919)披露羧基麦芽糖铁注射液上市许可申请获受理的公告,7月31日股价上涨1.62%
证券之星 · 07-31
金陵药业(000919)披露羧基麦芽糖铁注射液上市许可申请获受理的公告,7月31日股价上涨1.62%
股市必读:金陵药业(000919)7月27日董秘有最新回复
证券之星 · 07-28
股市必读:金陵药业(000919)7月27日董秘有最新回复
金陵药业(000919)7月20日股东户数4.18万户,较上期增加3.1%
证券之星 · 07-23
金陵药业(000919)7月20日股东户数4.18万户,较上期增加3.1%
金陵药业:截至2026年7月20日,公司股东人数为41,764
证券之星 · 07-23
金陵药业:截至2026年7月20日,公司股东人数为41,764
股市必读:金陵药业(000919)7月20日董秘有最新回复
证券之星 · 07-21
股市必读:金陵药业(000919)7月20日董秘有最新回复
股市必读:金陵药业(000919)股东户数4.05万户,较上期增加3.02%
证券之星 · 07-15
股市必读:金陵药业(000919)股东户数4.05万户,较上期增加3.02%
金陵药业:拥有药食同源类食品、金陵丝白系列化妆品
证券之星 · 07-14
金陵药业:拥有药食同源类食品、金陵丝白系列化妆品
金陵药业:截至2026年7月10日,公司股东人数为40,508
证券之星 · 07-14
金陵药业:截至2026年7月10日,公司股东人数为40,508
金陵药业(000919)披露公司产品进入《国家基本药物目录(2026年版)》公告,7月10日股价上涨2.34%
证券之星 · 07-10
金陵药业(000919)披露公司产品进入《国家基本药物目录(2026年版)》公告,7月10日股价上涨2.34%
股市必读:金陵药业(000919)7月6日董秘有最新回复
证券之星 · 07-07
股市必读:金陵药业(000919)7月6日董秘有最新回复
金陵药业:截至2026年6月30日,公司股东人数为39,321
证券之星 · 07-06
金陵药业:截至2026年6月30日,公司股东人数为39,321
金陵药业:公司持续聚焦主业、改善经营基本面,提升公司内在价值
证券之星 · 07-01
金陵药业:公司持续聚焦主业、改善经营基本面,提升公司内在价值
金陵药业:关于募资时间表,如有达到披露标准的事项公司将及时公告
证券之星 · 07-01
金陵药业:关于募资时间表,如有达到披露标准的事项公司将及时公告
金陵药业:公司目前控股四家综合性医院
证券之星 · 07-01
金陵药业:公司目前控股四家综合性医院
加载更多
公司概况
公司名称:
金陵药业股份有限公司
所属行业:
医药制造业
上市日期:
1999-11-18
主营业务:
金陵药业股份有限公司的主营业务是药品、医疗器械制造和销售,以及医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。公司一直致力于打造自身的品牌优势和较高的知名度,“桂冠”商标为中国驰名商标,“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品。“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。
发行价格:
8.40
{"stockData":{"symbol":"000919","market":"SZ","secType":"STK","nameCN":"金陵药业","latestPrice":6.71,"timestamp":1787641428000,"preClose":6.51,"halted":0,"volume":17386044,"delay":0,"changeRate":0.0307,"floatShares":622000000,"shares":622000000,"eps":0.0948,"marketStatus":"已收盘","change":0.2,"latestTime":"08-25 15:00:00","open":6.51,"high":6.73,"low":6.43,"amount":115000000,"amplitude":0.0461,"askPrice":6.72,"askSize":861,"bidPrice":6.71,"bidSize":187,"shortable":0,"etf":0,"ttmEps":0.0948,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":5,"adr":0,"adjPreClose":6.51,"symbolType":"stock","openAndCloseTimeList":[[1787621400000,1787628600000],[1787634000000,1787641200000]],"highLimit":7.16,"lowLimit":5.86,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":621924528,"isCdr":false,"pbRate":1.06,"roa":"--","peRate":70.780591,"roe":"0.74%","epsLYR":0.0867,"committee":-0.762186,"marketValue":4173000000,"turnoverRate":0.028,"status":0,"floatMarketCap":4172000000},"requestUrl":"/m/hq/s/000919","defaultTab":"news","newsList":[{"id":"2660465193","title":"金陵药业(000919)8月10日股东户数4.06万户,较上期增加0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660465193?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:28","pubTimestamp":1787045300,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金陵药业披露,截至2026年8月10日公司股东户数为4.06万户,较7月31日增加22.0户,增幅为0.05%。在化学制药行业个股中,金陵药业股东户数高于行业平均水平,截至8月10日,化学制药行业平均股东户数为3.64万户。从股价来看,2026年7月31日至2026年8月10日,金陵药业区间涨幅为4.61%,在此期间股东户数增加22.0户,增幅为0.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800030541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000919","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660409459","title":"金陵药业:截至2026年8月10日,公司股东人数为40,565","url":"https://stock-news.laohu8.com/highlight/detail?id=2660409459","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660409459?lang=zh_cn&edition=full","pubTime":"2026-08-18 11:33","pubTimestamp":1787023990,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)08月18日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!请问截止8月10号,公司的股东人数是多少?谢谢金陵药业回复:投资者,您好!截至2026年8月10日,公司股东人数为40,565,感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800016043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0239","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658964319","title":"金陵药业(000919)7月31日股东户数4.05万户,较上期减少2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658964319","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658964319?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:29","pubTimestamp":1786440551,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金陵药业披露,截至2026年7月31日公司股东户数为4.05万户,较7月20日减少1221.0户,减幅为2.92%。在化学制药行业个股中,金陵药业股东户数高于行业平均水平,截至7月31日,化学制药行业平均股东户数为3.59万户。从股价来看,2026年7月20日至2026年7月31日,金陵药业区间涨幅为0.32%,在此期间股东户数减少1221.0户,减幅为2.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100027988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658967097","title":"金陵药业:截至2026年7月31日,公司股东人数为40,543","url":"https://stock-news.laohu8.com/highlight/detail?id=2658967097","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658967097?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:07","pubTimestamp":1786432035,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!请问截止7月31号,公司的股东人数是多少?谢谢!金陵药业回复:投资者,您好!截至2026年7月31日,公司股东人数为40,543,感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100018907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000919","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657517205","title":"金陵药业(000919)7月31日股东户数4.05万户,较上期减少2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657517205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657517205?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:43","pubTimestamp":1785923018,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金陵药业披露,截至2026年7月31日公司股东户数为4.05万户,较7月20日减少1221.0户,减幅为2.92%。在化学制药行业个股中,金陵药业股东户数高于行业平均水平,截至7月31日,化学制药行业平均股东户数为3.59万户。从股价来看,2026年7月20日至2026年7月31日,金陵药业区间涨幅为0.32%,在此期间股东户数减少1221.0户,减幅为2.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657534516","title":"金陵药业:截至2026年7月31日,公司股东人数为40,543","url":"https://stock-news.laohu8.com/highlight/detail?id=2657534516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657534516?lang=zh_cn&edition=full","pubTime":"2026-08-05 15:06","pubTimestamp":1785913582,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截至7月30日公司股东人数是多少?金陵药业回复:投资者,您好!截至2026年7月31日,公司股东人数为40,543,感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500022844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655362714","title":"金陵药业(000919)披露羧基麦芽糖铁注射液上市许可申请获受理的公告,7月31日股价上涨1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655362714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655362714?lang=zh_cn&edition=full","pubTime":"2026-07-31 22:27","pubTimestamp":1785508041,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,金陵药业报收于6.29元,较前一交易日上涨1.62%,最新总市值为39.12亿元。该股当日开盘6.19元,最高6.29元,最低6.17元,成交额达6145.37万元,换手率为1.58%。近日,金陵药业股份有限公司福州梅峰制药厂提交的羧基麦芽糖铁注射液药品注册上市许可申请已获国家药品监督管理局受理。该产品为第三代静脉铁剂,用于治疗缺铁性贫血,目前国内仅有原研进口产品上市,尚无仿制药获批。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100042141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0239","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654447660","title":"股市必读:金陵药业(000919)7月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2654447660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654447660?lang=zh_cn&edition=full","pubTime":"2026-07-28 01:17","pubTimestamp":1785172629,"startTime":"0","endTime":"0","summary":"截至2026年7月27日收盘,金陵药业报收于6.15元,上涨2.33%,换手率1.68%,成交量10.44万手,成交额6390.33万元。交易信息汇总资金流向7月27日主力资金净流出282.8万元,占总成交额0.0%;游资资金净流出140.33万元,占总成交额0.0%;散户资金净流入423.13万元,占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800000700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0239","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653745530","title":"金陵药业(000919)7月20日股东户数4.18万户,较上期增加3.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653745530","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653745530?lang=zh_cn&edition=full","pubTime":"2026-07-23 17:52","pubTimestamp":1784800347,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金陵药业披露,截至2026年7月20日公司股东户数为4.18万户,较7月10日增加1256.0户,增幅为3.1%。在化学制药行业个股中,金陵药业股东户数高于行业平均水平,截至7月20日,化学制药行业平均股东户数为3.58万户。从股价来看,2026年7月10日至2026年7月20日,金陵药业区间涨幅为2.28%,在此期间股东户数增加1256.0户,增幅为3.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300036662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653713669","title":"金陵药业:截至2026年7月20日,公司股东人数为41,764","url":"https://stock-news.laohu8.com/highlight/detail?id=2653713669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653713669?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:42","pubTimestamp":1784778131,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截至7月20日公司股东人数是多少?金陵药业回复:投资者,您好!截至2026年7月20日,公司股东人数为41,764,感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300019828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0028","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653248569","title":"股市必读:金陵药业(000919)7月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653248569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653248569?lang=zh_cn&edition=full","pubTime":"2026-07-21 02:09","pubTimestamp":1784570950,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘,金陵药业报收于6.27元,上涨0.0%,换手率2.4%,成交量14.95万手,成交额9372.9万元。董秘最新回复投资者: 你好,传言公司要花几十亿收购一家制药企业?有关公司信息请以公司在法定信息披露媒体发布的公告为准。交易信息汇总资金流向7月20日主力资金净流出95.44万元,占总成交额0.0%;游资资金净流出72.39万元,占总成交额0.0%;散户资金净流入167.83万元,占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100001601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0239","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651548318","title":"股市必读:金陵药业(000919)股东户数4.05万户,较上期增加3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651548318","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651548318?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:56","pubTimestamp":1784051773,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘,金陵药业报收于6.37元,上涨3.07%,换手率3.11%,成交量19.35万手,成交额1.22亿元。股本股东变化股东户数变动截至2026年7月10日公司股东户数为4.05万户,较6月30日增加1187.0户,增幅为3.02%。户均持股数量由上期的1.58万股减少至1.54万股,户均持股市值为9.41万元。投资者: 董秘您好,请问截至7月10日公司股东人数是多少?截至2026年7月10日,公司股东人数为40,508,感谢您对公司的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0239","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651617558","title":"金陵药业:拥有药食同源类食品、金陵丝白系列化妆品","url":"https://stock-news.laohu8.com/highlight/detail?id=2651617558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651617558?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:33","pubTimestamp":1784017993,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业07月14日在投资者关系平台上答复投资者关心的问题。药膳、药妆依托药食同源与中药萃取技术,可充分复用现有制药产能与研发能力。凭借上市公司公信力、三甲医院专业背书,公司产品更容易获得消费者认可。目前公司拥有药食同源类食品、金陵丝白系列化妆品等大健康产品,但现阶段此类业务在公司整体营收中的占比较小。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400030912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0028","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651129355","title":"金陵药业:截至2026年7月10日,公司股东人数为40,508","url":"https://stock-news.laohu8.com/highlight/detail?id=2651129355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651129355?lang=zh_cn&edition=full","pubTime":"2026-07-14 11:38","pubTimestamp":1784000310,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,截止2026年7月10日股东人数具体多少?谢谢金陵药业回复:投资者,您好!截至2026年7月10日,公司股东人数为40,508,感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400019133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0028","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650913696","title":"金陵药业(000919)披露公司产品进入《国家基本药物目录(2026年版)》公告,7月10日股价上涨2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650913696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650913696?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:48","pubTimestamp":1783694893,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘,金陵药业报收于6.13元,较前一交易日上涨2.34%,最新总市值为38.12亿元。该股当日开盘5.96元,最高6.18元,最低5.89元,成交额达7581.79万元,换手率为2.0%。近日,国家卫生健康委员会等部门联合发布《国家基本药物目录》,自2026年9月1日起施行。金陵药业股份有限公司有2个新产品入选目录,分别为复方磺胺甲恶唑注射液和头孢克肟颗粒剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000045010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649676344","title":"股市必读:金陵药业(000919)7月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649676344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649676344?lang=zh_cn&edition=full","pubTime":"2026-07-07 02:32","pubTimestamp":1783362734,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘,金陵药业报收于6.23元,上涨0.81%,换手率2.45%,成交量15.23万手,成交额9459.3万元。董秘最新回复投资者: 董秘你好,截止2026年6月30日,公司股东人数具休多少?当日关注点交易信息汇总:7月6日主力资金净流出243.54万元,占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700001186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","000919","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649642850","title":"金陵药业:截至2026年6月30日,公司股东人数为39,321","url":"https://stock-news.laohu8.com/highlight/detail?id=2649642850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649642850?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:18","pubTimestamp":1783325904,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)07月06日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截止6月30日公司的股东人数是多少,谢谢!!金陵药业回复:投资者,您好!截至2026年6月30日,公司股东人数为39,321,感谢您对公司的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600021377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0096","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648518106","title":"金陵药业:公司持续聚焦主业、改善经营基本面,提升公司内在价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2648518106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648518106?lang=zh_cn&edition=full","pubTime":"2026-07-01 15:21","pubTimestamp":1782890469,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业07月01日在投资者关系平台上答复投资者关心的问题。公司持续聚焦主业、改善经营基本面,提升公司内在价值。后续如有达到披露标准的事项将及时履行公告义务,请您继续关注公司依法披露的相关公告和定期报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100023693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0239","BK0028","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648151816","title":"金陵药业:关于募资时间表,如有达到披露标准的事项公司将及时公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2648151816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648151816?lang=zh_cn&edition=full","pubTime":"2026-07-01 15:21","pubTimestamp":1782890469,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问:因为最多发200字,接上文的问题请董秘接着回答②7.5亿募资的时间表到底在哪?③管理层对二十年几乎零成长的复盘结论是什么?股东要行动,不要套话,谢谢。金陵药业回复:投资者,您好!关于募资时间表,如有达到披露标准的事项公司将及时公告,请您继续关注公司依法披露的相关公告和定期报告;公司持续复盘,总结经验,优化经营,改善基本面,提升内在价值。敬请理性决策、注意投资风险。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100023694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648518486","title":"金陵药业:公司目前控股四家综合性医院","url":"https://stock-news.laohu8.com/highlight/detail?id=2648518486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648518486?lang=zh_cn&edition=full","pubTime":"2026-07-01 15:21","pubTimestamp":1782890467,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,公司子公司好几家医院有没有机器人微创肝脏切除手术?公司医院能实施哪些大型微型人体手术,有哪些高新技术金陵药业回复:投资者,您好!公司目前控股四家综合性医院,分别是南京鼓楼医院集团宿迁医院、南京鼓楼医院集团安庆市石化医院、南京鼓楼医院集团仪征医院、南京梅山医院,此外公司还控股湖州康复医院,相关医疗信息您可查阅医院官方网站。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100023692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0239","000919"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787700365743,"stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.1165},{"period":"3month","weight":0.0964},{"period":"6month","weight":-0.0967},{"period":"1year","weight":-0.0606},{"period":"ytd","weight":-0.1422}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.0197},{"period":"3month","weight":-0.0499},{"period":"6month","weight":-0.062},{"period":"1year","weight":0.0015},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金陵药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"40565人(较上一季度增加0.05%)","perCapita":"15327股","listingDate":"1999-11-18","address":"江苏省南京市栖霞区经济技术开发区新港大道58号","registeredCapital":"62192万元","survey":" 金陵药业股份有限公司的主营业务是药品、医疗器械制造和销售,以及医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。公司一直致力于打造自身的品牌优势和较高的知名度,“桂冠”商标为中国驰名商标,“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品。“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。","listedPrice":8.4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金陵药业,000919,金陵药业股票,金陵药业股票老虎,金陵药业股票老虎国际,金陵药业行情,金陵药业股票行情,金陵药业股价,金陵药业股市,金陵药业股票价格,金陵药业股票交易,金陵药业股票购买,金陵药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}